Lab
Incyte Pathology, P.S.
Incyte Pathology, P.S. was paid $159K by Medicaid between Jan 2022 and Dec 2024, across 58 billing codes. Its largest line is 36415, Collection of venous blood by venipuncture — 13% of everything it billed.
33Billing provider infoINCYTE PATHOLOGY, P.S.
SPOKANE VALLEY, WA 99216
SPOKANE VALLEY, WA 99216
33aNPI1316251358assigned 08/02/2010
33bProvider typeClinical Medical Laboratory
28Total paid$159K
24GClaims25,095
24DCodes billed58
24AFirst – last monthJan 2022 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Washington
Rank by total paid#35 of 76
Median peer was paid$90K
This provider vs. median1.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 355 | $1K | |
| 2023 | 6,895 | $45K | |
| 2024incomplete | 17,845 | $113K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 36415 | Collection of venous blood by venipuncture | 13% | 5,511 | 4,970 | $20K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 10% | 3,240 | 2,958 | $17K |
| 84443 | Thyroid stimulating hormone (TSH) | 10% | 1,452 | 1,423 | $16K |
| 80053 | Comprehensive metabolic panel | 9.2% | 2,260 | 2,097 | $15K |
| 80061 | Lipid panel | 7.0% | 1,304 | 1,276 | $11K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 4.9% | 385 | 375 | $8K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.4% | 1,178 | 1,144 | $7K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 4.2% | 1,166 | 1,113 | $7K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3.9% | 333 | 329 | $6K |
| 86780 | 3.4% | 535 | 523 | $5K | |
| 84439 | 2.6% | 662 | 652 | $4K | |
| 86850 | 2.4% | 500 | 493 | $4K |
46 more codes
| 82728 | 2.3% | 380 | $4K | |
| 86803 | 2.1% | 314 | $3K | |
| 86762 | 2.1% | 314 | $3K | |
| 82607 | 1.9% | 292 | $3K | |
| 87186 | 1.7% | 414 | $3K | |
| 87340 | 1.6% | 327 | $3K | |
| 87077 | 1.1% | 358 | $2K | |
| 82746 | 1.1% | 151 | $2K | |
| 87088 | <1% | 335 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 378 | $2K |
| 83540 | <1% | 322 | $2K | |
| 87070 | <1% | 212 | $1K | |
| 84144 | <1% | 72 | $1K | |
| 84702 | <1% | 110 | $1K | |
| 82950 | <1% | 275 | $1K | |
| 86900 | <1% | 329 | $739.04 | |
| 86901 | <1% | 317 | $722.64 | |
| 83970 | <1% | 26 | $587.79 | |
| 85027 | <1% | 139 | $553.56 | |
| 84466 | <1% | 57 | $496.65 | |
| 87147 | <1% | 125 | $488.61 | |
| 83550 | <1% | 74 | $480.43 | |
| 81003 | <1% | 369 | $461.89 | |
| 83001 | <1% | 28 | $450.32 | |
| 82670 | <1% | 13 | $324.99 | |
| 82570 | <1% | 90 | $316.06 | |
| 86140 | <1% | 82 | $275.70 | |
| 85651 | <1% | 97 | $269.64 | |
| 86703 | <1% | 24 | $226.04 | |
| 84481 | <1% | 12 | $167.60 | |
| 82951 | <1% | 13 | $144.13 | |
| 86317 | <1% | 13 | $141.06 | |
| 87205 | <1% | 39 | $136.50 | |
| 80050 | General health panel | <1% | 195 | $134.64 |
| 86225 | <1% | 12 | $130.01 | |
| 86038 | <1% | 12 | $114.36 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 55 | $75.00 |
| 81001 | <1% | 38 | $71.33 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 24 | $58.68 |
| 83735 | <1% | 13 | $55.34 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 55 | $50.00 |
| 82952 | <1% | 13 | $43.92 | |
| 82043 | <1% | 12 | $39.30 | |
| 85610 | <1% | 13 | $38.16 | |
| 84550 | <1% | 13 | $35.47 | |
| 84156 | <1% | 13 | $22.02 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGOLDBERG, LINDA (CREDENTIALING SPECIALIST)
| Provider | Location | Paid |
|---|---|---|
| Incyte Pathology, P.S. | Spokane Valley, WA | $27.49M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.